David M. Livermore

机构：University of East Anglia · ORCID：0000-0002-9856-3703

发表论文 523 篇 · 总被引 49566 次 · h-index 114

代表论文

• OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline (2022 · Antimicrobial Agents and Chemotherapy · 被引 168)
• Multicentre evaluation of two multiplex PCR platforms for the rapid microbiological investigation of nosocomial pneumonia in UK ICUs: the INHALE WP1 study (2022 · Thorax · 被引 117)
• Understanding decisions about antibiotic prescribing in ICU: an application of the Necessity Concerns Framework (2021 · BMJ Quality & Safety · 被引 81)
• Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: Impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in Escherichia coli (2023 · International Journal of Antimicrobial Agents · 被引 69)
• SUsceptibility and Resistance to Fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: findings of the SURF study (2022 · International Journal of Antimicrobial Agents · 被引 54)
• INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia (2025 · Intensive Care Medicine · 被引 48)